128 related articles for article (PubMed ID: 29221130)
1. Development and cytotoxic response of two proliferative MDA-MB-231 and non-proliferative SUM1315 three-dimensional cell culture models of triple-negative basal-like breast cancer cell lines.
Dubois C; Dufour R; Daumar P; Aubel C; Szczepaniak C; Blavignac C; Mounetou E; Penault-Llorca F; Bamdad M
Oncotarget; 2017 Nov; 8(56):95316-95331. PubMed ID: 29221130
[TBL] [Abstract][Full Text] [Related]
2. The New Synthetic Serum-Free Medium OptiPASS Promotes High Proliferation and Drug Efficacy Prediction on Spheroids from MDA-MB-231 and SUM1315 Triple-Negative Breast Cancer Cell Lines.
Dubois C; Daumar P; Aubel C; Gauthier J; Vidalinc B; Mounetou E; Penault-Llorca F; Bamdad M
J Clin Med; 2019 Mar; 8(3):. PubMed ID: 30901969
[TBL] [Abstract][Full Text] [Related]
3. Low-Dose and Long-Term Olaparib Treatment Sensitizes MDA-MB-231 and SUM1315 Triple-Negative Breast Cancers Spheroids to Fractioned Radiotherapy.
Dubois C; Martin F; Hassel C; Magnier F; Daumar P; Aubel C; Guerder S; Mounetou E; Penault-Lorca F; Bamdad M
J Clin Med; 2019 Dec; 9(1):. PubMed ID: 31888054
[TBL] [Abstract][Full Text] [Related]
4. Differences in drug sensitivity between two-dimensional and three-dimensional culture systems in triple-negative breast cancer cell lines.
Muguruma M; Teraoka S; Miyahara K; Ueda A; Asaoka M; Okazaki M; Kawate T; Kuroda M; Miyagi Y; Ishikawa T
Biochem Biophys Res Commun; 2020 Dec; 533(3):268-274. PubMed ID: 32958246
[TBL] [Abstract][Full Text] [Related]
5. Bone Sialoprotein Shows Enhanced Expression in Early, High-Proliferation Stages of Three-Dimensional Spheroid Cell Cultures of Breast Cancer Cell Line MDA-MB-231.
Rustamov V; Keller F; Klicks J; Hafner M; Rudolf R
Front Oncol; 2019; 9():36. PubMed ID: 30805306
[TBL] [Abstract][Full Text] [Related]
6. Development of Breast Cancer Spheroids to Evaluate Cytotoxic Response to an Anticancer Peptide.
Cavaco M; Fraga P; Valle J; Andreu D; Castanho MARB; Neves V
Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834277
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Triple-Negative Breast Cancer MDA-MB-231 Cell Spheroid Model.
Huang Z; Yu P; Tang J
Onco Targets Ther; 2020; 13():5395-5405. PubMed ID: 32606757
[TBL] [Abstract][Full Text] [Related]
8. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
Oliveras-Ferraros C; Vazquez-Martin A; López-Bonet E; Martín-Castillo B; Del Barco S; Brunet J; Menendez JA
Int J Oncol; 2008 Dec; 33(6):1165-76. PubMed ID: 19020749
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of chemotherapeutics in a three-dimensional breast cancer model.
Lovitt CJ; Shelper TB; Avery VM
J Cancer Res Clin Oncol; 2015 May; 141(5):951-9. PubMed ID: 25773123
[TBL] [Abstract][Full Text] [Related]
10. The New Serum-Free OptiPASS
Goisnard A; Dubois C; Daumar P; Aubel C; Depresle M; Gauthier J; Vidalinc B; Penault-Llorca F; Mounetou E; Bamdad M
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33919619
[TBL] [Abstract][Full Text] [Related]
11. The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: implications for cancer therapy and prevention.
Zordoky BN; Bark D; Soltys CL; Sung MM; Dyck JR
Biochim Biophys Acta; 2014 Jun; 1840(6):1943-57. PubMed ID: 24462945
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of curcumin effects on breast adenocarcinoma 2D and 3D cell cultures.
Abuelba H; Cotrutz CE; Stoica BA; Stoica L; Olinici D; Petreuş T
Rom J Morphol Embryol; 2015; 56(1):71-6. PubMed ID: 25826489
[TBL] [Abstract][Full Text] [Related]
13. Infrared imaging of MDA-MB-231 breast cancer cell line phenotypes in 2D and 3D cultures.
Smolina M; Goormaghtigh E
Analyst; 2015 Apr; 140(7):2336-43. PubMed ID: 25568895
[TBL] [Abstract][Full Text] [Related]
14. Three dimensional spheroid cell culture for nanoparticle safety testing.
Sambale F; Lavrentieva A; Stahl F; Blume C; Stiesch M; Kasper C; Bahnemann D; Scheper T
J Biotechnol; 2015 Jul; 205():120-9. PubMed ID: 25595712
[TBL] [Abstract][Full Text] [Related]
15. Roles of acid-extruding ion transporters in regulation of breast cancer cell growth in a 3-dimensional microenvironment.
Andersen AP; Flinck M; Oernbo EK; Pedersen NB; Viuff BM; Pedersen SF
Mol Cancer; 2016 Jun; 15(1):45. PubMed ID: 27266704
[TBL] [Abstract][Full Text] [Related]
16. BCRP and P-gp relay overexpression in triple negative basal-like breast cancer cell line: a prospective role in resistance to Olaparib.
Dufour R; Daumar P; Mounetou E; Aubel C; Kwiatkowski F; Abrial C; Vatoux C; Penault-Llorca F; Bamdad M
Sci Rep; 2015 Aug; 5():12670. PubMed ID: 26234720
[TBL] [Abstract][Full Text] [Related]
17. Potent antitumor activity of cepharanthine against triple-negative breast cancer spheroids compared with tetrandrine.
Kiyomi A; Miyakawa R; Matsumoto J; Yamazaki K; Imai S; Yuan B; Hirano T; Sugiura M
Oncol Lett; 2020 Dec; 20(6):331. PubMed ID: 33101499
[TBL] [Abstract][Full Text] [Related]
18. β-Tubulin Isoforms Related to Docetaxel Sensitivity in 2D and 3D Cultured TNBC Cell Lines.
Muguruma M; Asaoka M; Teraoka S; Miyahara K; Kawate T; Ishikawa T
Anticancer Res; 2022 Oct; 42(10):4735-4742. PubMed ID: 36191981
[TBL] [Abstract][Full Text] [Related]
19. Prognostic relevance of carbonic anhydrase IX expression is distinct in various subtypes of breast cancer and its silencing suppresses self-renewal capacity of breast cancer cells.
Ivanova L; Zandberga E; Siliņa K; Kalniņa Z; Ābols A; Endzeliņš E; Vendina I; Romanchikova N; Hegmane A; Trapencieris P; Eglītis J; Linē A
Cancer Chemother Pharmacol; 2015 Feb; 75(2):235-46. PubMed ID: 25422154
[TBL] [Abstract][Full Text] [Related]
20. Diversity of cell-mediated adhesions in breast cancer spheroids.
Ivascu A; Kubbies M
Int J Oncol; 2007 Dec; 31(6):1403-13. PubMed ID: 17982667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
